Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Abstract Chemotherapy is a life‐saving treatment for cancer patients, but also causes long‐term cognitive impairment, or “chemobrain”, in survivors. However, several challenges, including imprecise diagnosis criteria, multiple confounding factors, and unclear and heterogeneous molecular mechanisms,...
Main Authors: | Lien D Nguyen, Barbara E Ehrlich |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2020-06-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.202012075 |
Similar Items
-
Chemobrain, Olfactory and Lifestyle Assessment in Onco-Geriatrics: Sex-Mediated Differences between Chemotherapy and Immunotherapy
by: Sara Invitto, et al.
Published: (2022-10-01) -
Editorial: Current trends on emotional processing: contributions of acquired brain injury, neurodegenerative diseases, and ageing
by: Beatriz García-Rodríguez, et al.
Published: (2024-02-01) -
The neural correlates of apathy in the context of aging and brain disorders: a meta-analysis of neuroimaging studies
by: Hongjie Yan, et al.
Published: (2023-06-01) -
Editorial: Advances and challenges of non-invasive brain stimulation in age-related neurodegenerative diseases, volume II
by: Yi Guo, et al.
Published: (2023-08-01) -
Age Moderates the Effect of Injury Severity on Functional Trajectories in Traumatic Brain Injury: A Study Using the NIDILRR Traumatic Brain Injury Model Systems National Dataset
by: Laraine Winter, et al.
Published: (2022-04-01)